One scientist at the FDA's Center for Tobacco Products said the center had delayed starting new applications while staff ...

MONTREAL and CHARLOTTE, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today announced the U.S. Food and Drug Administration (FDA) issued a Complete ...

DBV Technologies (DBVT) announced that in a written responses only to the company’s Type D IND meeting request, the FDA agreed with the ...

Eva Temkin, a lawyer at Arnold & Porter who advises clients on medical device applications, said the FDA had canceled some meetings with companies or reverted to providing written responses only.

CRL focused on CMC; no clinical issues relating to etripamil raised $69.7M in cash, cash equivalents and short-term investments as of December 31, 2024 MONTREAL and CHARLOTTE, N.C., March 28, 2025 ...